基于多参数MRI的影像组学模型与融合模型在慢性肝病患者肝纤维化分期中的比较
这项回顾性研究纳入接受多参数腹部MRI的慢性肝病患者,构建影像组学模型及整合APRI、FIB-4的融合模型用于肝纤维化分期。训练队列中两模型鉴别不同分组的AUC分别为0.707-0.842和0.718-0.854,测试队列分别为0.514-0.724和0.609-0.728;测试队列中融合模型鉴别F1-3 vs. F4和F1-2 vs. F4的AUC高于影像组学模型(p=0.011和0.042)。作者认为两种模型对慢性肝病肝纤维化分期具有可行性,APRI和FIB-4可提高影像组学模型在F1-3 vs. F4和F1-2 vs. F4中的诊断性能。
要点
- 测试队列中融合模型鉴别F1-3 vs. F4和F1-2 vs. F4的AUC高于影像组学模型(p=0.011和0.042)。
- 训练队列中两模型鉴别不同分组的AUC差异无统计学意义(p>0.05)。
- 融合模型在影像组学特征基础上整合了血清纤维化标志物APRI和FIB-4。
核心结论
- 基于多参数MRI的影像组学模型和融合模型对慢性肝病肝纤维化分期具有可行性,APRI和FIB-4可提高影像组学模型鉴别F1-3 vs. F4和F1-2 vs. F4的诊断性能。
研究设计与样本
- 回顾性研究,纳入接受多参数腹部MRI的慢性肝病患者;将多参数MR图像导入3D-Slicer软件在MR图像上绘制边界框,使用SlicerRadiomics扩展提取影像组学特征,采用z-score归一化方法进行后处理,采用LASSO方法筛选显著影像组学特征,采用逻辑回归分析构建影像组学模型,并将血清纤维化标志物APRI和FIB-4与影像组学特征整合构建融合模型。
诊断标准与关键数值
- 训练队列中影像组学模型和融合模型鉴别不同分组的AUC分别为0.707-0.842和0.718-0.854;测试队列中分别为0.514-0.724和0.609-0.728;训练队列中两模型AUC差异无统计学意义(p>0.05);测试队列中融合模型鉴别F1-3 vs. F4和F1-2 vs. F4的AUC高于影像组学模型(p=0.011和0.042)。
临床应用与阅片要点
- 作者认为基于多参数MRI的影像组学模型和融合模型对慢性肝病肝纤维化分期具有可行性,APRI和FIB-4可提高影像组学模型鉴别F1-3 vs. F4和F1-2 vs. F4的诊断性能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop and compare radiomics model and fusion model based on multiple MR parameters for staging liver fibrosis in patients with chronic liver disease.
MATERIALS AND METHODS: Patients with chronic liver disease who underwent multiparametric abdominal MRI were included in this retrospective study. Multiparametric MR images were imported into 3D-Slicer software for drawing bounding boxes on MR images. By using a 3D-Slicer extension of SlicerRadiomics, radiomics features were extracted from these MR images. The z-score normalization method was used for post-processing radiomics features. The least absolute shrinkage and selection operator method (LASSO) was performed for selecting significant radiomics features. The logistic regression analysis was used for building the radiomics model. A fusion model was built by integrating serum fibrosis biomarkers of aspartate transaminase-to-platelet ratio index (APRI) and the fibrosis-4 index (FIB-4) with radiomics signatures.
RESULTS: In the training cohort, AUCs of radiomics and fusion model were 0.707-0.842 and 0.718-0.854 for differentiating different groups. In the testing cohort, AUCs were 0.514-0.724 and 0.609-0.728. For the training cohort, there was no significant difference of AUCs between radiomics and fusion model (p > 0.05). For the testing cohort, AUCs of fusion model were higher than those of radiomics model in differentiating F1-3 vs. F4 and F1-2 vs. F4 (p = 0.011 & 0.042).
CONCLUSIONS: Radiomics model and fusion model based on multiparametric MRI exhibited the feasibility for staging liver fibrosis in patients with CLD, and APRI and FIB-4 could improve the diagnostic performance of radiomics model in differentiating F1-3 vs. F4 and F1-2 vs. F4.
引用
- Xiao L, Zhao H, Liu S, et al. Staging liver fibrosis: comparison of radiomics model and fusion model based on multiparametric MRI in patients with chronic liver disease. Abdom Radiol (NY). 2024. PMID: 38219254. doi:10.1007/s00261-023-04142-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。